Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Thinking of quitting a GLP-1? A physician outlines six risks, from weight regain and muscle loss to worsening biomarkers and mental health consequences.
FOX News
Full text, translation and AI summary — after signing in
- The full article in your language
- AI summary and translation from the original
- The same account works in the Suviy app
Related coverage
Comments
Sign in to join the conversation. Sign in
No comments yet.